• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有抗拓扑异构酶I抗体的重症系统性硬化症与HLA - DRw11等位基因相关。

Severe systemic sclerosis with anti-topoisomerase I antibodies is associated with an HLA-DRw11 allele.

作者信息

Morel P A, Chang H J, Wilson J W, Conte C, Saidman S L, Bray J D, Tweardy D J, Medsger T A

机构信息

Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, PA.

出版信息

Hum Immunol. 1994 Jun;40(2):101-10. doi: 10.1016/0198-8859(94)90054-x.

DOI:10.1016/0198-8859(94)90054-x
PMID:7928439
Abstract

SSc is an autoimmune connective tissue disease in which strong HLA associations have not been described. Anti-topo I antibodies are recognized, in general, in SSc patients with diffuse cutaneous involvement, whereas anti-ACAs are found in individuals with limited cutaneous involvement. We studied 95 Caucasian SSc patients, 44 with anti-topo I antibodies and 51 with neither anti-topo I nor ACA, for HLA-DR associations by using DNA typing techniques. We analyzed 181 normal Caucasian individuals in the same fashion. A significant association was observed in the anti-topo-I-positive patients with DRw11 (p = 1.7 x 10(-6), RR 4.2). The distribution of DRw11 alleles in these patients was significantly different from that observed in controls and could be accounted for by an increase in the frequency of the DRB1*1104 allele (p = 1.2 x 10(-9), RR 9.5). The DRw11 alleles were also associated with SSc with more tendon friction rubs (p = 0.006), which is a marker of more severe disease. In addition, a strong association was observed with anti-topo I antibodies and a particular sequence (aa 71-77) of the DQB1 chain (p = 0.02, RR 2.2). HLA associations in the case of SSc patients with anti-topo I antibodies are complex and involve at least two genes: HLA-DRw11, which appears to play a major role in determining the severity of the disease, and a DQ sequence, which associates with the development of the anti-topo I antibodies.

摘要

系统性硬化症(SSc)是一种自身免疫性结缔组织疾病,目前尚未发现其与HLA有很强的关联性。一般来说,抗拓扑异构酶I抗体在弥漫性皮肤受累的SSc患者中被识别出来,而抗着丝点抗体(ACAs)则在局限性皮肤受累的个体中被发现。我们采用DNA分型技术,研究了95例白种人SSc患者,其中44例有抗拓扑异构酶I抗体,51例既无抗拓扑异构酶I抗体也无抗着丝点抗体,以确定其与HLA - DR的关联性。我们以同样的方式分析了181例正常白种人个体。在抗拓扑异构酶I阳性患者中观察到与DRw11有显著关联(p = 1.7 x 10(-6),相对危险度RR = 4.2)。这些患者中DRw11等位基因的分布与对照组观察到的分布显著不同,这可能是由于DRB1*1104等位基因频率的增加所致(p = 1.2 x 10(-9),RR = 9.5)。DRw11等位基因还与有更多肌腱摩擦音的SSc相关(p = 0.006),这是疾病更严重的一个标志。此外,还观察到抗拓扑异构酶I抗体与DQB1链的一个特定序列(氨基酸71 - 77)有很强的关联(p = 0.02,RR = 2.2)。对于有抗拓扑异构酶I抗体的SSc患者,HLA的关联性很复杂,至少涉及两个基因:HLA - DRw11,它似乎在决定疾病严重程度方面起主要作用;以及一个DQ序列,它与抗拓扑异构酶I抗体的产生相关。

相似文献

1
Severe systemic sclerosis with anti-topoisomerase I antibodies is associated with an HLA-DRw11 allele.伴有抗拓扑异构酶I抗体的重症系统性硬化症与HLA - DRw11等位基因相关。
Hum Immunol. 1994 Jun;40(2):101-10. doi: 10.1016/0198-8859(94)90054-x.
2
Association of HLA class II genes with systemic sclerosis in Koreans.韩国人中HLA II类基因与系统性硬化症的关联。
J Rheumatol. 2001 Jul;28(7):1577-83.
3
Different distribution of HLA class II alleles in anti-topoisomerase I autoantibody responders between silicosis and systemic sclerosis patients, with a common distinct amino acid sequence in the HLA-DQB1 domain.矽肺患者和系统性硬化症患者中抗拓扑异构酶I自身抗体应答者之间HLA II类等位基因的分布不同,HLA-DQB1结构域存在一个共同的独特氨基酸序列。
Immunobiology. 2001 Dec;204(4):458-65. doi: 10.1078/0171-2985-00055.
4
MHC class II associations with autoantibody and T cell immune responses to the scleroderma autoantigen topoisomerase I.主要组织相容性复合体II类与针对硬皮病自身抗原拓扑异构酶I的自身抗体及T细胞免疫反应的关联
J Autoimmun. 2000 Dec;15(4):451-8. doi: 10.1006/jaut.2000.0447.
5
The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma).HLA - DR和DQ基因控制系统性硬化症(硬皮病)中针对DNA拓扑异构酶I的自身免疫反应。
J Clin Invest. 1993 Sep;92(3):1296-301. doi: 10.1172/JCI116703.
6
HLA and clinical associations in systemic sclerosis patients with anti-Th/To antibodies.抗Th/To抗体的系统性硬化症患者的HLA与临床关联
Arthritis Rheum. 1998 Jan;41(1):74-80. doi: 10.1002/1529-0131(199801)41:1<74::AID-ART10>3.0.CO;2-C.
7
HLA and ethnic associations among systemic sclerosis patients with anticentromere antibodies.抗着丝点抗体阳性系统性硬化症患者的HLA与种族关联
Hum Immunol. 1995 Jan;42(1):35-42. doi: 10.1016/0198-8859(94)00078-5.
8
Association of HLA class II genes with systemic sclerosis in Spanish patients.HLA Ⅱ类基因与西班牙系统性硬皮病患者的相关性研究。
J Rheumatol. 2009 Dec;36(12):2733-6. doi: 10.3899/jrheum.090377. Epub 2009 Nov 2.
9
Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin).对患有针对RNA聚合酶和U3 - RNP(原纤维蛋白)自身抗体的系统性硬化症患者的HLA - DR和DQ等位基因的研究。
J Rheumatol. 2000 May;27(5):1196-202.
10
Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.种族背景对系统性硬化症和抗DNA拓扑异构酶I抗体患者临床及血清学特征的影响。
Arthritis Rheum. 1999 Mar;42(3):465-74. doi: 10.1002/1529-0131(199904)42:3<465::AID-ANR11>3.0.CO;2-Y.

引用本文的文献

1
A Prospective Observational Study of Disease Severity and Mortality in Hispanic American Patients With Systemic Sclerosis.一项前瞻性观察研究: Hispanic 裔美国系统性硬化症患者的疾病严重程度和死亡率。
Arthritis Care Res (Hoboken). 2024 Jun;76(6):768-776. doi: 10.1002/acr.25300. Epub 2024 Mar 25.
2
Brief Report: HLA-DRB1, DQA1, and DQB1 in Juvenile-Onset Systemic Sclerosis.简报:幼年发病系统性硬化症中的 HLA-DRB1、DQA1 和 DQB1。
Arthritis Rheumatol. 2016 Nov;68(11):2772-2777. doi: 10.1002/art.39765. Epub 2016 Oct 6.
3
HLA Class I and II Blocks Are Associated to Susceptibility, Clinical Subtypes and Autoantibodies in Mexican Systemic Sclerosis (SSc) Patients.
HLA I类和II类基因座与墨西哥系统性硬化症(SSc)患者的易感性、临床亚型及自身抗体相关。
PLoS One. 2015 May 20;10(5):e0126727. doi: 10.1371/journal.pone.0126727. eCollection 2015.
4
Systemic Sclerosis is a Complex Disease Associated Mainly with Immune Regulatory and Inflammatory Genes.系统性硬化症是一种主要与免疫调节和炎症基因相关的复杂疾病。
Open Rheumatol J. 2014 Sep 29;8:29-42. doi: 10.2174/1874312901408010029. eCollection 2014.
5
Recent advances in understanding the pathogenesis of scleroderma-interstitial lung disease.硬皮病-间质性肺疾病发病机制研究的最新进展
Curr Rheumatol Rep. 2014 Apr;16(4):411. doi: 10.1007/s11926-014-0411-1.
6
HLA markers for poor prognosis in systemic sclerosis Brazilian patients.HLA 标志物与巴西系统性硬皮病患者预后不良相关。
Dis Markers. 2013;35(2):73-8. doi: 10.1155/2013/301415. Epub 2013 Jul 28.
7
Association of HLA-DRB1*15:02 and DRB5*01:02 allele with the susceptibility to systemic sclerosis in Thai patients.HLA-DRB1*15:02 和 DRB5*01:02 等位基因与泰国系统性硬化症患者易感性的关联。
Rheumatol Int. 2013 Aug;33(8):2069-77. doi: 10.1007/s00296-013-2686-3. Epub 2013 Feb 13.
8
Novel sequence feature variant type analysis of the HLA genetic association in systemic sclerosis.新型 HLA 遗传关联序列特征变异类型分析在系统性硬化症中的应用。
Hum Mol Genet. 2010 Feb 15;19(4):707-19. doi: 10.1093/hmg/ddp521. Epub 2009 Nov 18.
9
Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls.主要组织相容性复合体 (MHC) Ⅱ类等位基因、单倍型和表位在系统性硬化症中易感性或保护作用的分析:在 1300 例白种人、非裔美国人和西班牙裔病例和 1000 例对照中进行的分析。
Ann Rheum Dis. 2010 May;69(5):822-7. doi: 10.1136/ard.2009.111906. Epub 2009 Jul 12.
10
Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies.经典人类白细胞抗原基因座的平衡选择与异质性:对497项人群研究的荟萃分析综述
Hum Immunol. 2008 Jul;69(7):443-64. doi: 10.1016/j.humimm.2008.05.001. Epub 2008 Jun 9.